---
title: "SNDX SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Syndax Pharmaceuticals (SNDX), with links to the SEC filings."
url: "https://tradytics.com/research/SNDX/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=SNDX&v=stock-11994868"
---

# SNDX financial statements and SEC filings

## SNDX annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $172.35M | -$273.08M | -$285.42M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2024-12-31 | $23.68M | -$339.67M | -$318.76M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2023-12-31 | $0.00 | -$229.95M | -$209.36M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2022-12-31 | $0.00 | -$151.76M | -$149.34M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017025030394/0000950170-25-030394-index.htm) |
| 2021-12-31 | $139.71M | $26.22M | $24.93M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/0000950170-24-021253-index.htm) |
| 2020-12-31 | $1.52M | -$71.42M | -$77.06M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017023005079/0000950170-23-005079-index.htm) |

## SNDX annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $529.71M | $465.08M | $64.63M | [10-Q](https://www.sec.gov/Archives/edgar/data/1395937/000119312526443625/0001193125-26-443625-index.htm) |
| 2024-12-31 | $724.82M | $436.69M | $288.12M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2023-12-31 | $612.88M | $58.68M | $554.20M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017025030394/0000950170-25-030394-index.htm) |
| 2022-12-31 | $497.24M | $29.79M | $467.45M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/0000950170-24-021253-index.htm) |
| 2021-12-31 | $449.66M | $41.29M | $408.37M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017023005079/0000950170-23-005079-index.htm) |
| 2020-12-31 | $300.61M | $48.42M | $252.19M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000156459022008112/0001564590-22-008112-index.htm) |

## SNDX annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$322.98M | -$187.00K | $13.68M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2024-12-31 | -$274.90M | $0.00 | $353.37M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2023-12-31 | -$160.60M | $0.00 | $264.13M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000119312526076536/0001193125-26-076536-index.htm) |
| 2022-12-31 | -$133.68M | $0.00 | $172.25M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017025030394/0000950170-25-030394-index.htm) |
| 2021-12-31 | $29.13M | -$129.00K | $118.46M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017024021253/0000950170-24-021253-index.htm) |
| 2020-12-31 | -$71.26M | $0.00 | $304.42M | [10-K](https://www.sec.gov/Archives/edgar/data/1395937/000095017023005079/0000950170-23-005079-index.htm) |

- [SNDX stock research](https://tradytics.com/research/SNDX)
- [SNDX financial summary](https://tradytics.com/research/SNDX/financials)
- [Read the data without JavaScript](https://tradytics.com/research/SNDX/fundamentals?snapshot=1)
